These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16893907

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan.
    Gawlik KI, Durbeej M.
    Muscle Nerve; 2010 Jul; 42(1):30-7. PubMed ID: 20544910
    [Abstract] [Full Text] [Related]

  • 3. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
    Ringelmann B, Röder C, Hallmann R, Maley M, Davies M, Grounds M, Sorokin L.
    Exp Cell Res; 1999 Jan 10; 246(1):165-82. PubMed ID: 9882526
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.
    Bentzinger CF, Barzaghi P, Lin S, Ruegg MA.
    FASEB J; 2005 Jun 10; 19(8):934-42. PubMed ID: 15923403
    [Abstract] [Full Text] [Related]

  • 5. Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice.
    Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M.
    Hum Mol Genet; 2004 Aug 15; 13(16):1775-84. PubMed ID: 15213105
    [Abstract] [Full Text] [Related]

  • 6. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
    Meinen S, Barzaghi P, Lin S, Lochmüller H, Ruegg MA.
    J Cell Biol; 2007 Mar 26; 176(7):979-93. PubMed ID: 17389231
    [Abstract] [Full Text] [Related]

  • 7. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
    Patton BL, Wang B, Tarumi YS, Seburn KL, Burgess RW.
    J Cell Sci; 2008 May 15; 121(Pt 10):1593-604. PubMed ID: 18430779
    [Abstract] [Full Text] [Related]

  • 8. CD90-positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy(3k)/dy(3k) mice.
    Fukada S, Yamamoto Y, Segawa M, Sakamoto K, Nakajima M, Sato M, Morikawa D, Uezumi A, Miyagoe-Suzuki Y, Takeda S, Tsujikawa K, Yamamoto H.
    Exp Cell Res; 2008 Jan 01; 314(1):193-203. PubMed ID: 17963748
    [Abstract] [Full Text] [Related]

  • 9. Laminin α1 reduces muscular dystrophy in dy2J mice.
    Gawlik KI, Harandi VM, Cheong RY, Petersén Å, Durbeej M.
    Matrix Biol; 2018 Sep 01; 70():36-49. PubMed ID: 29544677
    [Abstract] [Full Text] [Related]

  • 10. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Moll J, Barzaghi P, Lin S, Bezakova G, Lochmüller H, Engvall E, Müller U, Ruegg MA.
    Nature; 2001 Sep 20; 413(6853):302-7. PubMed ID: 11565031
    [Abstract] [Full Text] [Related]

  • 11. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
    Vilquin JT, Guérette B, Puymirat J, Yaffe D, Tomé FM, Fardeau M, Fiszman M, Schwartz K, Tremblay JP.
    Gene Ther; 1999 May 20; 6(5):792-800. PubMed ID: 10505103
    [Abstract] [Full Text] [Related]

  • 12. Merosin and congenital muscular dystrophy.
    Miyagoe-Suzuki Y, Nakagawa M, Takeda S.
    Microsc Res Tech; 1999 May 20; 48(3-4):181-91. PubMed ID: 10679965
    [Abstract] [Full Text] [Related]

  • 13. Gene expression profiling of diaphragm muscle in alpha2-laminin (merosin)-deficient dy/dy dystrophic mice.
    van Lunteren E, Moyer M, Leahy P.
    Physiol Genomics; 2006 Mar 13; 25(1):85-95. PubMed ID: 16368874
    [Abstract] [Full Text] [Related]

  • 14. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
    Saito F, Masaki T, Saito Y, Nakamura A, Takeda S, Shimizu T, Toda T, Matsumura K.
    J Neurochem; 2007 Jun 13; 101(6):1712-22. PubMed ID: 17326765
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
    Kuang W, Xu H, Vachon PH, Liu L, Loechel F, Wewer UM, Engvall E.
    J Clin Invest; 1998 Aug 15; 102(4):844-52. PubMed ID: 9710454
    [Abstract] [Full Text] [Related]

  • 17. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M, Kurahashi H, Noguchi S, Sese J, Okinaga T, Tsukahara T, Guicheney P, Ozono K, Nishino I, Morishita S, Toda T.
    Biochem Biophys Res Commun; 2006 Apr 07; 342(2):489-502. PubMed ID: 16487936
    [Abstract] [Full Text] [Related]

  • 18. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
    Körner Z, Fontes-Oliveira CC, Holmberg J, Carmignac V, Durbeej M.
    Am J Pathol; 2014 May 07; 184(5):1518-28. PubMed ID: 24631023
    [Abstract] [Full Text] [Related]

  • 19. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
    Gawlik KI, Holmberg J, Durbeej M.
    Am J Pathol; 2014 Mar 07; 184(3):740-52. PubMed ID: 24393714
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.